Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap as of August 2026

World Top 100 Healthcare Companies List by Market Cap as of August 2026, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as of August 2026.

Metatag Title
World Top Healthcare Companies in 2026
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2026, World Top Healthcare Companies by Market Cap in 2026.
  1. Shanghai Pharmaceuticals Holding Co. Ltd

    World Rank (Aug-2026)
    2,395
    Market Cap (Aug-2026)
    8.933 Billion USD
    World Rank (Jan-05-2024)
    2,027
    Market Cap (Jan-05-2024)
    7.917 Billion USD
    World Rank (Jul-30-2023)
    1,712
    Market Cap (Jul-30-2023)
    9.736 Billion USD
    World Rank (Dec-25-2022)
    1,713
    Market Cap (Dec-25-2022)
    8.717 Billion USD
    World Rank (Jan-07-2022)
    2,269
    Market Cap (Jan-07-2022)
    7.95 Billion USD
    Annual Revenue in USD
    41,080 Million USD
    Annual Operating Income in USD
    1,345 Million USD
    Annual Net Income in USD
    829 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Pharmaceutical company with headquarters is in China.
  2. Qiagen

    World Rank (Aug-2026)
    2,413
    Market Cap (Aug-2026)
    8.851 Billion USD
    World Rank (Jan-05-2024)
    1,657
    Market Cap (Jan-05-2024)
    9.994 Billion USD
    World Rank (Jul-30-2023)
    1,592
    Market Cap (Jul-30-2023)
    10.745 Billion USD
    World Rank (Dec-25-2022)
    1,395
    Market Cap (Dec-25-2022)
    11.228 Billion USD
    World Rank (Jan-07-2022)
    1,676
    Market Cap (Jan-07-2022)
    11.46 Billion USD
    Annual Revenue in USD
    2,090 Million USD
    Annual Operating Income in USD
    520 Million USD
    Annual Net Income in USD
    425 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile

    Pharmaceutical and research company with headquarters is in Germany.

  3. Bruker Corporation

    World Rank (Aug-2026)
    2,425
    Market Cap (Aug-2026)
    8.791 Billion USD
    World Rank (Jan-05-2024)
    1,691
    Market Cap (Jan-05-2024)
    9.741 Billion USD
    World Rank (Jul-30-2023)
    1,659
    Market Cap (Jul-30-2023)
    10.146 Billion USD
    World Rank (Dec-25-2022)
    1,562
    Market Cap (Dec-25-2022)
    9.787 Billion USD
    World Rank (Jan-07-2022)
    1,706
    Market Cap (Jan-07-2022)
    11.25 Billion USD
    Annual Revenue in USD
    3,437 Million USD
    Annual Operating Income in USD
    68 Million USD
    Annual Net Income in USD
    -9 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Bruker Corporation is a Healthcare, BioTechnology and Medical Equipment manufacturing company. The company products are mass spectrometry and separations, infrared, near Infrared and Raman spectroscopy, X-ray diffraction and elemental analysis, magnetic resonance, surface and dimensional analysis, preclinical imaging, fluorescence microscopes, micro tomography, semiconductor metrology. The headquarters is in USA.

  4. HealthEquity

    World Rank (Aug-2026)
    2,431
    Market Cap (Aug-2026)
    8.756 Billion USD
    World Rank (Jan-05-2024)
    2,575
    Market Cap (Jan-05-2024)
    5.884 Billion USD
    World Rank (Jul-30-2023)
    2,713
    Market Cap (Jul-30-2023)
    5.538 Billion USD
    World Rank (Dec-25-2022)
    2,637
    Market Cap (Dec-25-2022)
    5.216 Billion USD
    World Rank (Jan-07-2022)
    4,063
    Market Cap (Jan-07-2022)
    3.80 Billion USD
    Annual Revenue in USD
    1,313 Million USD
    Annual Operating Income in USD
    322 Million USD
    Annual Net Income in USD
    215 Million USD
    Annual Results for Period Ending
    For year ending January-2026
    Headquarters Country
    Company Profile

    HealthEquity is a Healthcare company. It is having More than two million members are paying less for health insurance, taking control of medical bills and building health savings for life with HealthEquity health savings accounts. The headquarters is in USA.

  5. Asymchem Laboratories (Tianjin)

    World Rank (Aug-2026)
    2,437
    Market Cap (Aug-2026)
    8.723 Billion USD
    World Rank (Jan-05-2024)
    2,720
    Market Cap (Jan-05-2024)
    5.496 Billion USD
    World Rank (Jul-30-2023)
    2,458
    Market Cap (Jul-30-2023)
    6.228 Billion USD
    World Rank (Dec-25-2022)
    2,100
    Market Cap (Dec-25-2022)
    6.769 Billion USD
    World Rank (Jan-07-2022)
    1,418
    Market Cap (Jan-07-2022)
    14.21 Billion USD
    Annual Revenue in USD
    966 Million USD
    Annual Operating Income in USD
    182 Million USD
    Annual Net Income in USD
    164 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Asymchem is a Pharmaceutical company. The company range from early clinical stage to commercial stage including R&D (Research and development) and cGMP(Current Good Manufacturing Practice) production of advanced intermediates, APIs (Application Programming Interface), formulations as well as clinical research services. It is having 3,840 employees as on 2019. The headquarters is in China.
  6. Reata Pharmaceuticals

    World Rank (Aug-2026)
    2,443
    World Rank (Jan-05-2024)
    2,443
    World Rank (Jul-30-2023)
    2,443
    Market Cap (Jul-30-2023)
    6.278 Billion USD
    World Rank (Dec-25-2022)
    7,125
    Market Cap (Dec-25-2022)
    1.319 Billion USD
    World Rank (Jan-07-2022)
    9,134
    Market Cap (Jan-07-2022)
    1.05 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Net Income in USD
    -312 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    Company Profile

    Reata Pharmaceuticals is a Bio-pharmaceutical company with headquarters is in Texas, USA.

    Biogen acquired Reata Pharmaceuticals for 7.3 Billion USD in 2023.

  7. Eisai

    World Rank (Aug-2026)
    2,453
    Market Cap (Aug-2026)
    8.647 Billion USD
    World Rank (Jan-05-2024)
    1,230
    Market Cap (Jan-05-2024)
    14.345 Billion USD
    World Rank (Jul-30-2023)
    995
    Market Cap (Jul-30-2023)
    18.227 Billion USD
    World Rank (Dec-25-2022)
    881
    Market Cap (Dec-25-2022)
    18.732 Billion USD
    World Rank (Jan-07-2022)
    1,258
    Market Cap (Jan-07-2022)
    16.12 Billion USD
    Annual Revenue in USD
    5,593 Million USD
    Annual Operating Income in USD
    299 Million USD
    Annual Net Income in USD
    261 Million USD
    Annual Results for Period Ending
    For year ending March-2026
    Headquarters Country
    Stock Category
    Company Profile

    Eisai is Pharmaceutical and Healthcare Products company with headquarters is in Tokyo, Japan.

    Facts About Company

    For year ending March-2023, Eisai annual revenue was 744 billion JPY, annual operating income was 40 billion JPY and annual net income was 55.4 billion JPY.

    Eisai had 11,076 employees as on 2023.

    It had 15 Drug Discovery, Research and Development, and Clinical Research Sites and 9 Production sites.

  8. Vaxcyte Inc.

    World Rank (Aug-2026)
    2,456
    Market Cap (Aug-2026)
    8.641 Billion USD
    World Rank (Jan-05-2024)
    2,495
    Market Cap (Jan-05-2024)
    6.122 Billion USD
    World Rank (Jul-30-2023)
    3,324
    Market Cap (Jul-30-2023)
    4.376 Billion USD
    World Rank (Dec-25-2022)
    3,506
    Market Cap (Dec-25-2022)
    3.686 Billion USD
    World Rank (Jan-07-2022)
    8,241
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Annual Operating Income in USD
    -924 Million USD
    Annual Net Income in USD
    -767 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Vaxcyte is a Biotechnology company developing potentially superior and novel vaccines designed to prevent or treat the most common and deadly infectious diseases worldwide. It is having 43 employees as on 2019. The headquarters is in USA.

  9. Immunovant

    World Rank (Aug-2026)
    2,458
    Market Cap (Aug-2026)
    8.638 Billion USD
    World Rank (Jan-05-2024)
    2,674
    Market Cap (Jan-05-2024)
    5.626 Billion USD
    World Rank (Jul-30-2023)
    4,418
    Market Cap (Jul-30-2023)
    2.942 Billion USD
    World Rank (Dec-25-2022)
    7,090
    Market Cap (Dec-25-2022)
    1.328 Billion USD
    World Rank (Jan-07-2022)
    9,880
    Market Cap (Jan-07-2022)
    0.92 Billion USD
    Annual Net Income in USD
    -506 Million USD
    Annual Results for Period Ending
    For year ending March-2026
    Headquarters Country
    Company Profile
    Immunovant is a Clinical Stage Biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The headquarters is in USA.
  10. Kyowa Kirin

    World Rank (Aug-2026)
    2,474
    Market Cap (Aug-2026)
    8.521 Billion USD
    World Rank (Jan-05-2024)
    1,811
    Market Cap (Jan-05-2024)
    8.943 Billion USD
    World Rank (Jul-30-2023)
    1,644
    Market Cap (Jul-30-2023)
    10.251 Billion USD
    World Rank (Dec-25-2022)
    1,297
    Market Cap (Dec-25-2022)
    12.269 Billion USD
    World Rank (Jan-07-2022)
    1,412
    Market Cap (Jan-07-2022)
    14.25 Billion USD
    Annual Revenue in USD
    3,367 Million USD
    Annual Operating Income in USD
    693 Million USD
    Annual Net Income in USD
    454 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Stock Category
    Company Profile
    Kyowa Kirin is a company that develops, manufactures, and markets pharmaceuticals. The Company produces anti-allergic agent, treating hypertension and angina pectoris agent, ulcerative colitis agent, anti-epileptic agent, and more. The headquarters is in Japan.

Share

Ads